Ave Maria Biotech, Inc. (AMB) was founded in direct response to the global health vulnerabilities exposed by the COVID-19 outbreak. The Company’s flagship device, the BD-500, offers real-time detection of airborne viruses and other pathogens, empowering businesses, healthcare facilities, the military, and public spaces to take immediate action based on accurate data. Today AMB works in a Cooperative Research and Development Agreement with US Army DEVCOM.
Company Details
- Employees
- 4
- Founded
- 2023
- Address
- 5050 Ave Maria Blvd, Ave Maria,florida 34142,united States
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://avemariabiotech.com/
- Keywords
- Cover2 Capital LLC.
- HQ
- Ave Maria, Florida
Ave Maria Biotech Questions
Ave Maria Biotech's website is https://avemariabiotech.com/
Ave Maria Biotech's LinkedIn profile is https://www.linkedin.com/company/ave-maria-biotech
Ave Maria Biotech has
4 employees.
View email and phone details for 4
employees at Ave Maria Biotech.
Ave Maria Biotech's industry is
Biotechnology Research
Ave Maria Biotech's top competitors are
Apex Growth Capital,
Social Canvas,
Americano Media,
Burro Outdoor Gear,
The Channel Group, Llc,
Two River,
Rational Energy Llc,
Impact Analytics Llc,
Stealth Mode Genai Startup,
Cover2 Capital Llc.
Ave Maria Biotech's categories are Biotechnology Research
Ave Maria Biotech's founding year is 2023
